Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis
- 31 March 2001
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 107 (3), 519-525
- https://doi.org/10.1067/mai.2001.112942
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Tacrolimus Ointment does not Affect Collagen Synthesis: Results of a Single-Center Randomized TrialJournal of Investigative Dermatology, 1998
- FcεRI-expressing antigen-presenting cells: new players in the atopic gameImmunology Today, 1997
- Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseasesJournal of Allergy and Clinical Immunology, 1995
- Lesional expression of interferon-γ in atopic eczemaThe Lancet, 1994
- Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skinBritish Journal of Dermatology, 1993
- The skin immune system: progress in cutaneous biologyImmunology Today, 1993
- Inhibition of contact allergy reactions by topical FK506The Lancet, 1992
- Cyclosporin A Inhibits the Antigen-Presenting Functions of Freshly Isolated Human Langerhans Cells In VitroJournal of Investigative Dermatology, 1991
- Occurrence of IgE-Bearing Epidermal Langerhans Cells in Atopic Eczema: A Study of the Time Course of the Lesions and With Regard to the IgE Serum LevelJournal of Investigative Dermatology, 1989
- The presence of IgE on macrophages and dendritic cells infiltrating into the skin lesion of atopic dermatitisClinical Immunology and Immunopathology, 1987